Loading...
01/10 19:54
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A reveal a positive outlook with raised revenue and EBITDA guidance, strong product development, and international expansion. The Q&A section highlighted analysts' positive sentiment towards international deals and growth in various segments, including software and services. Despite some concerns about competition and tariffs, the overall sentiment remains positive, supported by strong bookings growth and strategic investments. The raised guidance and optimistic future outlook suggest a positive stock price reaction over the next two weeks.
Third quarter revenue $711 million, increased 31% year-over-year. This marks the seventh consecutive quarter of 30% or greater growth, driven by robust demand.
Software and services revenue $305 million, increased 41% year-over-year. Growth reflects both new customers and existing customers expanding their use of the platform and capabilities.
Net revenue retention 124%, consistent with the previous quarter, indicating strong customer retention and expansion.
Annual Recurring Revenue (ARR) $1.3 billion, increased 41% year-over-year, driven by strong demand for recurring software services.
Connected Devices revenue $405 million, increased 24% year-over-year, reflecting broad-based demand.
TASER revenue Increased 17% year-over-year, led by TASER 10.
Personal Sensors revenue Increased 20% year-over-year, driven by Axon Body 4.
Platform Solutions revenue Increased 71% year-over-year, driven by counter drone, virtual reality, and fleet solutions.
Adjusted gross margin 62.7%, decreased 50 basis points year-over-year, primarily due to tariffs and scaling of lower-margin Platform Solutions.
Adjusted EBITDA margin 24.9%, reflecting the impact of tariffs and planned increased R&D investments into future growth categories.
Axon 911: Built on Prepared and Carbyne, it unifies technology for better outcomes. Prepared uses AI to handle noncritical calls and assist operators, while Carbyne replaces legacy call center infrastructure with cloud solutions.
ABW Mini: Second enterprise body camera introduced, opening new enterprise opportunities.
AI Era Plan: Fastest booked Axon software product to date, contributing over 10% of U.S. state and local bookings for the year.
International Expansion: Two of the top 10 deals in Q3 were international, including a 9-figure cloud deal in Europe. Growing adoption of TASER 10 in international markets.
Corrections Market: Contributed two of the top 10 deals in Q3, with year-to-date bookings up more than 2x from last year.
Revenue Growth: Q3 revenue of $711 million, a 31% year-over-year increase. Software and services revenue grew 41% to $305 million.
Net Revenue Retention: Maintained strong retention at 124%, with ARR growing 41% to $1.3 billion.
Adjusted EBITDA Margin: Achieved 24.9% despite tariffs and increased R&D investments.
Acquisitions: Acquired Prepared and announced Carbyne to enhance AI and cloud capabilities.
R&D Investments: Focused on vehicle intelligence, ALPR products, Axon Body Workforce Mini, and AI Era Plan features like live translation and policy chat.
Regulatory and Tariff Impacts: The company faced a decrease in adjusted gross margin due to tariffs impacting them for the first full quarter, which could continue to affect profitability.
Scaling Platform Solutions: Platform Solutions, while growing rapidly, has lower margins compared to other product lines like TASER and personal sensors, which could impact overall profitability.
R&D Investments: Increased R&D investments into new products and features, while promising, could strain short-term financial performance if returns are delayed or underperform expectations.
Acquisition Integration: Recent acquisitions such as Prepared and Carbyne, while strategically aligned, require significant integration efforts and investments, which could pose operational and financial risks.
International Expansion: While international markets are growing, the shift to cloud products in some countries is still in its early stages, which could delay revenue realization and growth in these regions.
Economic Uncertainty: Broader economic conditions and uncertainties could impact customer budgets, particularly in state and local government sectors, potentially affecting demand for Axon's products.
Competitive Pressures: The company operates in a competitive market, and its ability to maintain leadership and innovation is critical to sustaining growth.
Revenue Guidance: Q4 revenue is expected to be between $750 million and $755 million, implying full-year revenue of approximately $2.74 billion, up from the previous guidance of $2.65 billion to $2.73 billion. This represents approximately 31% growth at the midpoint.
Adjusted EBITDA Margin: Q4 adjusted EBITDA is expected to be between $178 million and $182 million, maintaining the full-year 25% margin target despite the impact of tariffs and increased R&D investments.
Future Growth Investments: Strategic investments in vehicle intelligence ALPR products, Axon Body Workforce Mini, and new AI Era Plan features such as live translation and policy chat are expected to deliver strong ROI over the long term.
Acquisitions Impact: Recent acquisitions, including Prepared and Carbyne, are expected to advance long-term vision and customer solutions. While immaterial financially at close, they are seen as key to future growth.
International Growth: International markets are expected to see larger deals, driven by the adoption of cloud products and TASER 10. A 9-figure cloud deal in Europe closed in October, signaling potential for further acceleration.
Bookings Growth: Year-to-date bookings are up over 30% and accelerating, with line of sight to close the year even stronger. Record growth is anticipated for 2026.
The selected topic was not discussed during the call.
The earnings call summary and Q&A reveal a positive outlook with raised revenue and EBITDA guidance, strong product development, and international expansion. The Q&A section highlighted analysts' positive sentiment towards international deals and growth in various segments, including software and services. Despite some concerns about competition and tariffs, the overall sentiment remains positive, supported by strong bookings growth and strategic investments. The raised guidance and optimistic future outlook suggest a positive stock price reaction over the next two weeks.
The earnings call summary shows strong financial performance with a 50% increase in bookings and significant demand for AI products. The Q&A section indicates positive sentiment from analysts, with confidence in international growth and new product adoption. Although management was unclear on some details, the overall outlook is optimistic, especially with the AI Era Plan and counter-drone success. The combination of strong financial metrics, optimistic guidance, and product development suggests a positive stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
